CHRISTOPHER J ROBLES

Allopathic & Osteopathic Physicians|Family Medicine SOMERS, NY NPI 1982915088

General Payments — all program years on this page

$1,506.98

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 88
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $418.14 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $418.1420

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $141.947
ABBVIE INC. $85.804
PFIZER INC. $54.883
Inspire Medical Systems, Inc. $42.722
Novo Nordisk AS $42.642
GlaxoSmithKline, LLC. $26.631
Otsuka America Pharmaceutical, Inc. $23.531

By program year

Program yearAmountRecords
2018 $436.6829
2019 $242.1917
2020 $51.104
2021 $90.564
2022 $135.917
2023 $132.407
2024 $418.1420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097122202 Novo Nordisk Inc $24.24 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097183155 Novo Nordisk Inc $18.40 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105961072 ABBVIE INC. $25.35 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105961074 ABBVIE INC. $20.75 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105961076 ABBVIE INC. $23.80 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105961078 ABBVIE INC. $15.90 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116696729 GlaxoSmithKline, LLC. $26.63 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118970441 Otsuka America Pharmaceutical, Inc. $23.53 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130935195 PFIZER INC. $17.05 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130968831 PFIZER INC. $21.15 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131275572 PFIZER INC. $16.68 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136097502 Lilly USA, LLC $20.12 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136097504 Lilly USA, LLC $17.20 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136097506 Lilly USA, LLC $23.45 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136100092 Lilly USA, LLC $12.44 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136101490 Lilly USA, LLC $30.89 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136110842 Lilly USA, LLC $17.89 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136115368 Lilly USA, LLC $19.95 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148102484 Inspire Medical Systems, Inc. $22.57 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148102488 Inspire Medical Systems, Inc. $20.15 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.